All News

In recent history, drug shortages became somewhat of a phenomenon, tripling from 61 shortages in 2005 to 178 in 2010.

In a Directions in Oncology Pharmacy Peer Exchange series, experts discuss the PRIMA trial and the rationale for using PARP inhibitors.

The study, called DELIVER: A Phase 3b Safety Study of the Dapivirine Ring and PrEP in Pregnant Women, will complement an ongoing NIH-funded trial of PrEP in adolescents and young women during pregnancy and the first 6 months after birth.

When combining a drug that is known to cause beta cells to proliferate with another drug that is already in widespread use in people with diabetes, it will cause the cells to proliferate at a rate of 5% to 6% per day, according to the study authors.

Enfortumab vedotin-ejfv in combination with the anti-PD1-therapy pembrolizumab for the treatment of patients with unresectable locally advanced or metastatic urothelial cancer who are unable to receive cisplatin-based chemotherapy in the first-line setting.

Dengue is endemic in the United States territories of American Samoa, Guam, Puerto Rico, and the US Virgin Islands.

Fears surrounding the COVID-19 outbreak have had major effects even in unaffected areas, including face mask shortages, a falling stock market, and many unsubstantiated rumors.

Politicians on both sides of the aisle have long been debating key issues in modern health care, including rising drug prices, access to care, and national addiction rates. Despite some agreement on which issues are most pressing, arguments persist in how to address them heading into the 2020 presidential election.

Pharmacists at Benzer Pharmacy will begin to offer DisposeRx packets during comprehensive in-person consultations to patients with unused and expired medications at home.

The FDA has accepted Genentech’s supplemental biologics license application (sBLA) and granted priority review for atezolizumab (Tecentriq) as a first-line monotherapy for some patients with advanced non-squamous and squamous non-small cell lung cancer (NSCLC).

Over the past 30 years, health plans have changed from primarily conventional health care coverage to alternatives such as health maintenance organizations and, most recently, high deductible health plans.

A study funded by the National Institutes of Health (NIH) found that despite similar rates of enrollment into medical care, youth with HIV have much lower rates of viral suppression compared with adults.

Top news from across the health care landscape.

Pharmacists are the primary drivers of their destiny, according to a new report, and they will continue to drive change in the industry by demonstrating their value, securing compensation, and advocating for expanded roles.

The duration of lactation was found to be a favorable glucose metabolic biomarker profile among women with a history of gestational diabetes mellitus.

Operation Broadsword, was the agency’s first bilateral enforcement operation with the Government of India.

Per capita health spending for 160 million Americans in employer-sponsored health plans grew by 4.4% in 2018, marking the third consecutive year of growth above 4%.

In the current chaotic environment of reimbursement that depends on quality and cost savings, pharmacists should increase their presence.

Over 90% of hospice and palliative care patients are prescribed opioid medications for pain management, and many individuals receive home care.

Suzanne Soliman, PharmD, founder of the Pharmacist Moms Group, said she believes that every situation is different when it comes to choosing the best remedy for children.

Simplici-T1 is the first study to test activation of glucokinase in patients with type 1 diabetes by evaluating daily oral TTP399 as an adjunct to insulin therapy.

In a recent study, researchers hypothesize providers’ safety concerns about treatment as a potential barrier.

Diclofenac sodium topical gel was first approved by the FDA in 2007 as a prescription drug, and was indicated for the relief of osteoarthritis pain in joints responsive to topical treatment, particularly the joints of the hands, knees, and feet.

In the pivotal phase 3 KEYNOTE-355 study, pembrolizumab (Keytruda, Merck) combined with chemotherapy met one of its dual primary endpoints of progression-free survival (PFS) as a first-line treatment for patients with metastatic triple-negative breast cancer (TNBC) whose tumors expressed programmed death-ligand 1 (PD-L1).

Top news from across the health care landscape.

New on-demand approach could aid where the absence of pharmacies, physician offices, or basic refrigeration makes it difficult to access critical medicines, daily use chemicals, and other small-molecule compounds.

The once-daily solution will be the first once-daily eye-itch allergy-relief drop to be available without a prescription in the United States.

Why is your patient using clonazepam for burning mouth syndrome?